Last updated on November 2015

Comparison of Thromboembolic Events Between Enoxa and Lovenox in Patients Undergoing Digestive Cancer


Brief description of study

Comparison of thromboembolic events between Enoxa® and Lovenox® in patients undergoing digestive cancer and subjected to thromboprophylaxis.

Detailed Study Description

Comparative study with two arms versus ENOXA® LOVENOX®, randomized, prospective, single-center, with rater-blinded whose main objective is to compare the incidence of thromboembolic events (symptomatic and asymptomatic) between the two arms of the study, in patients undergoing digestive cancer and receiving thromboprophylaxis based SODIUM enoxaparin.

Clinical Study Identifier: NCT02444572

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Chadli DZIRI, MD

Hospital Charle Nicolle
Tunis, Tunisia
  Connect »